Eventide Asset Management
Eventide Asset Management reported 347 stocks worth $7.1B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are GH (4.7%), XMTR (3.1%) and TT (2.6%). Compared with Q2 2026, the fund opened new positions in PLD, AGEN and ALAB, added to TT, TRGP and BBNX, trimmed GH, LRCX and ASML and sold out of BBIO, AMLX and SION.
Latest filing: what Eventide Asset Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() GH Guardant Health Inc | $332M | 4.7% | 1.9M | −98K (−5%) | 8 of 8 | |
| 2 | ![]() XMTR Xometry Inc | $221M | 3.1% | 2.2M | No change | 8 of 8 | |
| 3 | ![]() TT Trane Technologies PLC | $189M | 2.6% | 419K | +3,799 (+1%) | 8 of 8 | |
| 4 | ![]() LRCX Lam Research Corp | $187M | 2.6% | 570K | −103K (−15%) | 8 of 8 | |
| 5 | ![]() TRGP Targa Res Corp | $135M | 1.9% | 497K | +6,499 (+1%) | 8 of 8 | |
| 6 | ![]() BBNX Beta Bionics Inc | $134M | 1.9% | 7M | +791K (+13%) | 7 of 8 | |
| 7 | ![]() ASML Asml Holding N V | $123M | 1.7% | 68K | −400 (−1%) | 8 of 8 | |
| 8 | ![]() URI United Rentals Inc | $114M | 1.6% | 114K | +10K (+10%) | 7 of 8 | |
| 9 | ![]() MIRM Mirum Pharmaceuticals Inc | $107M | 1.5% | 1.2M | No change | 8 of 8 | |
| 10 | ![]() ARGX Argenx SE | $106M | 1.5% | 111K | −15K (−12%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
APOGEE THERAPEUTICS INC | $34.5M | 260K |
![]() BBIO Bridgebio Pharma Inc | $32.6M | 437K |
![]() AMLX Amylyx Pharmaceuticals Inc | $23.8M | 1.3M |
![]() SION Sionna Therapeutics Inc | $20.9M | 475K |
![]() STRO Sutro Biopharma Inc | $19.4M | 585K |
🔒 Free account: see all 19.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Eventide Asset Management 13F FAQ
What does Eventide Asset Management own?
Eventide Asset Management reported 347 stocks worth $7.1B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are GH (4.7%), XMTR (3.1%) and TT (2.6%). The table above lists every position in the filing (the top 10 without an account).
What did Eventide Asset Management buy and sell in Q3 2026?
Compared with Q2 2026: 65 new positions, 191 added to, 60 trimmed and 19 sold out. New positions include PLD, AGEN and ALAB. It sold all of BBIO, AMLX and SION.
When will Eventide Asset Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Eventide Asset Management's portfolio worth?
The Q3 2026 filing reports $7.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
























